Skip to main content
Indivior PLC logo

Indivior PLC — Investor Relations & Filings

Ticker · INDV ISIN · GB00BN4HT335 LEI · 213800V3NCQTY7IED471 IL Manufacturing
Filings indexed 1,983 across all filing types
Latest filing 2025-07-31 Regulatory Filings
Country GB United Kingdom
Listing IL INDV

About Indivior PLC

https://www.indivior.com/en

Indivior PLC is a global pharmaceutical company that develops, manufactures, and sells medicines to treat substance use disorders (SUD) and serious mental illnesses. The company's primary focus is on pioneering treatments for opioid use disorder (OUD), with a portfolio centered on buprenorphine-based prescription pharmaceuticals. Through its research and development efforts, Indivior aims to address the complex challenges of addiction and behavioral health by providing innovative, life-transforming therapies for patients worldwide.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2025-07-31 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-07-29 English
Indivior Announces Completion of London Delisting
Delisting Announcement Classification · 100% confidence The document is an official announcement from Indivior PLC regarding the completion of the cancellation of its secondary listing on the London Stock Exchange. Since the document explicitly states that the delisting has occurred and provides details on the status of the company's primary listing on Nasdaq, it falls under the category of a delisting announcement.
2025-07-25 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Barclays PLC regarding Indivior PLC. This is a regulatory requirement for shareholders to disclose when their voting rights cross specific thresholds. This fits the definition of a Major Shareholding Notification (MRQ).
2025-07-24 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Barclays PLC regarding Indivior PLC. This is a regulatory requirement for shareholders to disclose when their voting rights cross specific thresholds. This fits the definition of a 'Major Shareholding Notification' (MRQ).
2025-07-24 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 2130S' and contains the standard boilerplate text referencing 'RNS, the news service of the London Stock Exchange' and the FCA. The content itself is a 'TR-1: Standard form for notification of major holdings' detailing changes in voting rights held by Barclays PLC in Indivior PLC. This type of filing, which reports changes in significant share ownership crossing notification thresholds, directly corresponds to the Major Shareholding Notification category (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2025-07-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.